Clinical Trials Logo

Medical Termination of Pregnancy clinical trials

View clinical trials related to Medical Termination of Pregnancy.

Filter by:
  • None
  • Page 1

NCT ID: NCT05202639 Completed - Clinical trials for Medical Termination of Pregnancy

Decision-making Regarding the Possibility of Medical Termination of Pregnancy

DEFIMEG
Start date: December 15, 2021
Phase:
Study type: Observational

The aim of this study is to improve professional practices by better understanding parents who face the choice of medical termination of pregnancy. The hypothesis of the study is that the decision to continue the pregnancy with a serious fetal pathology is more based on the belief and the representations of parents than on the diagnosis or prognosis criteria of the fetus. A better understanding of the parents' motivations on their decision making by knowing what they expect from the caregivers would allow the division of representations, a better prenatal advice and a better perinatal support.

NCT ID: NCT04294212 Recruiting - Clinical trials for Medical Termination of Pregnancy

Medical Termination of Pregnancy : Evaluation of Patients' Practices and Feelings in Brest Hospital

IMGEPR
Start date: February 10, 2020
Phase:
Study type: Observational

This study evaluate the feelings of patients about a medical termination of pregnancy that they experienced in Brest Hospital. Patients responded to an online questionnaire assessing their feelings at each stage of the medical termination process. Their answers were associated with their medical data.

NCT ID: NCT02614781 Completed - Clinical trials for Medical Termination of Pregnancy

Efficacy of Mifepristone - Prostaglandin Analogue Combination in Medical Termination of Pregnancy Beyond 7 Weeks of Amenorrhea

Start date: November 2015
Phase: N/A
Study type: Observational

This study is a non-interventional prospective, multicenter, longitudinal study conducted in France, among a representative sample of public and/or private birth control centers. The aim of the study is to assess, in real-life settings, the success rate of the protocol Mifegyne / prostaglandin analogue in patients asking for medical abortion either prior or beyond 7 weeks of amenorrhea.

NCT ID: NCT02171845 Recruiting - Clinical trials for Voluntary Termination of Pregnancy

Mechanisms and Factors Responsible for the Inhibition of Transposons During Fetal Gonad Development in Humans

Start date: January 29, 2014
Phase:
Study type: Observational

This is a single-centre study over 36 months for the inclusion of 30 patients. The selection and inclusion of patients will take place according to the criterion of Medical Termination of Pregnancy at 4 different gestational ages (8-12 weeks of gestation (WG)), 13-16 WG, 17-23 WG and 25-35 WG. The tissue analysed will principally be the gonads, other somatic tissue will also be systematically harvested in parallel (liver and psoas muscle) for control purposes. The gonads will be subjected to molecular biology analyses destined to quantify the expression of transposons and their inhibitors.